Back to Article List

Denied health claims on blood pressure reduction

European Union

May 18, 2022

Commission Regulation (EU) 2022/727 of 11 May 2022 refusing to authorise a health claim made on foods and referring to the reduction of disease risk

Rejected health claim

Application – Relevant provisions of Regulation (EC) No 1924/2006

Nutrient, substance, food or food category


EFSA opinion reference

Article 14(1)(a) health claim referring to a reduction of a disease risk.

‘Symbiosal®’ (a food supplement containing sea salt (97 %) plus chitosan (3 %)).

‘Symbiosal®’ has been shown to lower the rising of blood pressure when used as a replacement of traditional table salt. The rising of blood pressure is a risk factor for high blood pressure (hypertension).



For further information (in English), click on the Link

Related Articles
See All News
Subscribe to our newsletter

The best industry insight in your mailbox